Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
2don MSN
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer ...
AZN wins the EU nod for Imfinzi in early gastric and GEJ cancers, backed by strong survival data and expanding its ...
Dale experienced acid reflux for years and originally thought it was just down to stress and working long hours ...
Sydney, Australia Monday, March 16, 2026, 10:00 Hrs [IST] ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs.
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the ...
The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results